background
middl
east
respiratori
syndrom
coronaviru
merscov
zoonot
infect
caus
sever
viral
pneumonia
index
case
resid
recent
travel
arabian
peninsula
global
concern
public
health
limit
humantohuman
transmiss
lead
case
cluster
report
merscov
report
dromedari
camel
phenotyp
characteris
virus
limit
aim
compar
merscov
isol
dromedari
saudi
arabia
egypt
prototyp
human
merscov
assess
viru
replic
compet
cell
tropism
exvivo
cultur
human
bronchu
lung
method
characteris
merscov
virus
dromedari
saudi
arabia
egypt
compar
human
merscov
refer
strain
assess
viral
replic
kinet
compet
cell
rhesu
monkey
tissu
tropism
cultur
exvivo
human
bronchial
lung
tissu
cytokin
chemokin
induct
gene
express
quantifi
cation
viral
rna
cell
human
respiratori
tract
use
mockinfect
tissu
neg
control
exvivo
experi
infl
uenza
posit
control
cytokin
chemokin
induct
experi
cell
interpret
similar
viru
tropism
replic
compet
human
dromedari
merscov
arabian
peninsula
genet
divers
dromedari
virus
egypt
exvivo
cultur
human
respiratori
tract
suggest
dromedari
virus
saudi
arabia
egypt
probabl
infecti
human
be
exposur
zoonot
merscov
probabl
occur
wider
geograph
region
beyond
arabian
peninsula
fund
middl
east
respiratori
syndrom
coronaviru
merscov
diseas
public
health
concern
global
laboratoryconfi
rmed
case
death
report
juli
indexcas
patient
resid
recent
travel
arabian
peninsula
adjac
countri
travelassoci
case
secondari
transmiss
aris
case
report
europ
north
america
africa
asia
case
cluster
associ
limit
humantohuman
transmiss
occur
within
famili
healthcar
set
remain
sporad
case
presum
zoonot
origin
recent
increas
report
case
saudi
arabia
associ
healthcar
facil
particular
caus
concern
establish
proxim
zoonot
sourc
human
infect
mode
transmiss
anim
human
be
remain
crucial
public
health
merscov
detect
dromedari
camel
camelu
dromedariu
associ
preced
human
infect
dromedari
slaughterhous
farm
virus
recent
human
case
arabian
peninsula
phylogenet
cluster
within
clade
b
earliest
human
merscov
strain
genet
distinct
denot
clade
dromedari
merscov
strain
detect
arabian
peninsula
clade
b
virus
phylogenet
relat
virus
human
case
region
genet
divers
nonclad
ab
virus
report
egypt
research
also
report
serolog
evid
collect
merscov
infect
dromedari
camel
serum
sampl
tunisia
nigeria
ethiopia
egypt
suggest
merscov
antigen
relat
virus
might
geograph
widespread
appreci
present
find
two
studi
peopl
saudi
arabia
peopl
egypt
work
dromedari
abattoir
show
remain
seroneg
merscov
suggest
tran
mission
human
uncommon
rais
question
whether
dromedari
merscov
strain
capac
infect
human
be
full
genom
sequenc
dromedari
virus
suggest
virus
similar
virus
human
aminoacid
diff
erenc
human
dromedari
virus
includ
genet
sequenc
spike
protein
major
determin
host
specifi
citi
aff
ect
receptor
bind
interfac
cell
receptor
howev
singl
aminoacid
chang
profoundli
aff
ect
host
rang
host
rang
determin
merscov
well
defi
ned
dromedari
virus
need
phenotyp
characteris
physiolog
relev
manner
far
viru
isol
dromedari
avail
biolog
characteris
direct
evid
replic
compet
dromedari
merscov
human
respiratori
tissu
lack
biolog
characteris
dromedari
merscov
viru
far
fi
nding
viru
replic
cell
transform
human
hepatoma
cell
line
physiolog
unrel
human
respiratori
tract
aim
compar
merscov
isol
dromedari
saudi
arabia
egypt
prototyp
human
merscov
emc
strain
assess
viru
replic
compet
cell
tropism
exvivo
cultur
human
bronchu
lung
use
human
merscov
strain
emc
hmerscov
provid
r
fouchier
erasmu
univers
medic
center
rotterdam
netherland
prepar
emc
viru
stock
previous
describ
three
dromedari
camel
strain
two
saudi
arabia
one
egypt
prepar
dromedari
camel
merscov
isol
isol
cell
atcc
manassa
va
usa
nasal
faecal
swab
collect
dromedari
alhasa
saudi
arabia
previous
describ
detect
dromedari
camel
merscov
nasal
swab
dromedari
abattoir
egypt
previous
report
studi
success
isol
viru
specimen
cell
previous
describ
virus
grown
aliquot
store
use
dromedari
merscov
strain
use
studi
passag
isol
cell
previous
compar
full
genom
sequenc
viru
origin
nasal
swab
passag
viru
use
access
number
viru
genom
retriev
analysi
method
viral
titrat
describ
appendix
method
use
exvivo
organ
cultur
infect
quantifi
cation
viral
rna
host
cytokin
chemokin
mrna
quantifi
cation
protein
immunohistochemistri
previous
describ
also
detail
appendix
experi
live
merscov
biosafeti
level
biocontain
facil
univers
hong
kong
studi
approv
institut
review
board
univers
hong
konghospit
author
hong
kong
west
cluster
cultur
cell
use
dulbecco
modifi
ed
eagl
medium
cell
seed
cell
per
well
tissuecultur
plate
infect
merscov
strain
multipl
infect
indic
h
viru
adsorpt
remov
viru
inoculum
wash
cell
phosphatebuff
ere
salin
pb
three
time
remov
unbound
viru
replenish
fresh
cultur
medium
measur
viru
replic
kinet
titrat
infecti
viru
infect
cultur
supernat
humanrespiratorytractderiv
cell
line
atcc
manassa
va
usa
cultur
infect
viru
cell
rna
infect
cell
also
collect
h
post
infect
analysi
gene
express
quantifi
cation
viral
rna
harvest
ml
cultur
supernat
cell
h
post
infect
measur
cytokin
chemokin
protein
concentr
use
elisa
r
system
minneapoli
mn
usa
cytomet
bead
array
bd
bioscienc
san
jose
ca
usa
use
method
specifi
ed
manufactur
posit
control
assess
cytokin
chemokin
induct
use
highli
pathogen
avian
infl
uenza
viru
ahong
infl
uenza
viru
prepar
madindarbi
canin
kidney
cell
previous
describ
creat
thermal
inactiv
curv
coronavirus
use
cultur
well
inocul
viru
dilut
absenc
permiss
cell
exvivo
cultur
mous
lung
prepar
mice
mous
lung
cultur
prepar
similar
exvivo
organ
cultur
human
sampl
ad
ml
viru
dilut
plate
diff
erent
start
concentr
tcid
ml
collect
supernat
h
post
incub
measur
viral
titrat
assess
tissu
tropism
ex
vivo
experi
infect
bronchial
lung
tissu
ml
merscov
viru
dilut
titr
tissu
cultur
infect
dose
per
ml
tcid
ml
incub
h
wash
cultur
three
time
ml
warm
pb
remov
unbound
viru
mockinocul
tissu
serv
control
ml
dulbecco
modifi
ed
eagl
medium
without
viru
collect
cultur
supernat
infect
cultur
h
post
infect
titrat
parallel
infecti
viru
use
tcid
assay
sampl
experi
exvivo
cultur
human
bronchu
lung
provid
fi
independ
donor
assess
extent
overal
viral
replic
areaundercurv
analysi
use
trapezoid
rule
use
area
calcul
h
post
infect
limit
detect
infecti
viru
titr
analysi
result
four
virus
compar
nonparametr
friedman
test
experi
cell
three
biolog
replic
cell
line
calcul
mean
standard
error
mean
sem
compar
diff
erenc
log
transform
viral
titr
twoway
anova
follow
bonferroni
multiplecomparison
test
compar
quantit
cytokin
chemokin
mrna
virus
time
twoway
anova
follow
bonferroni
multiplecomparison
test
protein
concentr
cytokin
chemokin
virus
h
post
infect
compar
oneway
anova
follow
bonferroni
multiplecomparison
test
see
onlin
appendix
use
p
less
indic
statist
signific
statist
analys
done
graphpad
prism
version
mac
funder
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
fi
nal
respons
decis
submit
public
figur
show
phylogeni
mer
cov
strain
use
studi
within
global
context
merscov
merscov
full
genom
sequenc
includ
analysi
virus
cluster
within
clade
b
merscov
includ
dromedari
camel
viru
isol
saudi
arabia
use
studi
prototyp
human
merscov
viru
emc
clade
viru
dromedari
merscov
isol
long
branch
phylogenet
tree
separ
clade
clade
b
virus
also
suggest
genet
divers
previous
describ
merscov
use
dromedari
merscov
isol
studi
nucleotid
aminoacid
similar
human
dromedari
camel
virus
provid
appendix
four
merscov
strain
replic
effi
cientli
cell
multipl
infect
fi
gure
tabl
egyptian
dromedari
merscov
replic
least
well
human
merscov
emc
reach
peak
titr
even
faster
human
merscov
h
post
infect
infect
low
multipl
infect
although
two
saudi
dromedari
merscov
strain
replic
less
effi
cientli
human
merscov
fi
rst
h
post
infect
viral
titr
similar
h
post
infect
replic
dromedari
merscov
signifi
cantli
higher
two
dromedari
merscov
strain
h
h
post
infect
multipl
infect
immunohistochemistri
exvivo
cultur
human
bronchu
lung
infect
human
dromedari
merscov
strain
suggest
four
virus
could
infect
tissu
fi
gure
threedimension
natur
infect
exvivo
cultur
nonuniform
throughout
histolog
specimen
appendix
figur
show
viral
replic
kinet
virus
exvivo
cultur
human
bronchu
lung
absenc
permiss
cell
thermal
inactiv
curv
merscov
strain
show
viru
infect
larg
decreas
undetect
level
h
post
infect
fi
gure
note
similar
thermal
inactiv
kinet
substitut
mous
lung
tissu
nonpermiss
merscov
human
exvivo
tissu
data
shown
although
extent
viru
replic
vari
donor
donor
comparison
thermal
inactiv
curv
provid
convinc
evid
viru
replic
four
virus
exvivo
human
bronchial
fi
gure
lung
fi
gure
cultur
donor
h
experi
period
two
replic
exvivo
cultur
per
donor
three
donor
infect
viru
human
merscov
emc
diff
erent
occas
show
chang
areaundercurv
tissu
donor
bronchu
rang
lung
rang
provid
indic
rang
technic
variat
exvivo
assay
appendix
contrast
diff
erenc
areaundercurv
human
merscov
emc
donor
donor
bronchu
area
curv
detect
limit
donor
patchi
natur
infect
variat
donor
lack
adequ
statist
power
statist
comparison
virus
interpret
caution
within
limit
note
signifi
cant
diff
erenc
replic
compet
four
virus
either
bronchu
lung
assess
areaunderthecurv
use
friedman
test
appendix
immunohistochem
analysi
virusinfect
bronchial
tissu
show
type
cell
infect
human
dromedari
merscov
similar
fi
gure
costain
viral
antigen
goblet
cell
marker
fi
gure
ciliat
cell
marker
fi
gure
lent
support
notion
merscov
infect
noncili
bronchial
epithelium
goblet
cell
costain
viral
antigen
alveolar
epitheli
cell
marker
show
four
virus
infect
alveolar
epitheli
cell
fi
gure
costain
alveolar
type
ii
epitheli
cell
marker
prosurfact
protein
c
show
type
ii
alveolar
epithelium
infect
fi
gure
note
evid
infect
alveolar
macrophag
fi
gure
four
virus
infect
lung
endothelium
appendix
thu
overal
respiratori
tropism
human
dromedari
merscov
similar
three
merscov
strain
emc
replic
effi
cientli
cell
includ
clade
quantifi
viral
rna
cytokin
chemokin
gene
induct
express
humanrespiratorytractderiv
cell
line
cultur
infect
viru
cell
rna
infect
cell
also
collect
h
post
infect
analysi
gene
express
quantifi
cation
viral
rna
harvest
ml
cultur
supernat
cell
h
post
infect
measur
cytokin
chemokin
protein
concentr
use
elisa
r
system
minneapoli
mn
usa
cytometr
bead
array
bd
bioscienc
san
jose
ca
usa
use
method
specifi
ed
manufactur
posit
control
assess
cytokin
chemokin
induct
use
highli
pathogen
avian
infl
uenza
viru
ahong
infl
uenza
viru
prepar
madindarbi
canin
kidney
cell
previous
describ
despit
effi
cient
replic
none
merscov
strain
induc
signifi
cant
gene
express
protein
secret
tumour
necrosi
factor
interferon
fi
gure
use
infl
uenza
viru
potent
induc
interferon
epitheli
cell
comparison
note
evid
interleukin
induct
three
merscov
strain
although
induc
greater
product
interleukin
mrna
human
emc
strain
human
emc
strain
induc
higher
concentr
interleukin
protein
either
dromedari
strain
fi
gure
compar
viral
replic
compet
respiratori
tropism
three
merscov
isol
dromedari
camel
prototyp
human
clade
merscov
isol
emc
panel
two
dromedari
merscov
isol
alhasa
phylogenet
close
relat
recent
clade
b
human
virus
saudi
arabia
shown
longbranch
unroot
phylogenet
tree
fi
gure
genet
similar
tabl
appendix
egyptian
dromedari
merscov
dromedari
merscov
genet
diverg
merscov
detect
date
also
diverg
suggest
global
divers
merscov
wider
previous
appreci
lack
repres
human
clade
b
merscov
isol
limit
studi
comparison
viral
genet
data
provid
clue
fi
nal
evid
compet
anim
viru
infect
human
be
sar
coronaviru
two
aminoacid
chang
spike
protein
strikingli
alter
abil
viru
transmit
effi
cientli
human
be
crucial
determin
host
tropism
merscov
fulli
understood
especi
outsid
spikereceptor
bind
domain
phenotyp
virus
provid
essenti
complementari
inform
genet
analysi
three
merscov
isol
dromedari
camel
similar
human
merscov
emc
viru
replic
compet
rhesu
monkey
cell
line
four
virus
replic
exvivo
cultur
human
bronchu
lung
infect
cell
type
bronchu
noncili
bronchial
epithelium
lung
alveolar
epithelium
includ
type
ii
alveolar
epitheli
cell
note
infect
lung
endotheli
cell
four
virus
suggest
potenti
dissemin
beyond
respiratori
tract
also
compar
overal
tropism
human
merscov
emc
human
respiratori
tract
similar
previous
report
phenotyp
human
dromedari
merscov
much
tropism
replic
compet
human
respiratori
exvivo
cultur
knowledg
report
provid
fi
rst
compar
data
live
human
respiratori
tissu
situ
therefor
studi
provid
new
crucial
inform
emerg
understand
diseas
global
import
public
health
heterogen
viru
replic
individu
donor
exvivo
infect
experi
might
result
diff
erenc
host
suscept
physiolog
relev
report
epidemiolog
human
mer
could
impli
individu
variat
might
import
determin
diseas
suscept
sever
howev
question
need
systemat
investig
thu
overal
data
support
complement
viral
genet
sequenc
data
spike
protein
dromedari
virus
seem
similar
spike
protein
human
merscov
strain
strongli
suggest
dromedari
merscov
strain
capac
infect
human
be
infect
exvivo
cultur
provid
use
inform
viru
cell
tropism
absenc
autopsi
data
mer
exvivo
organ
cultur
provid
inform
viru
tropism
earli
stage
infect
usual
avail
autopsi
patient
latestag
diseas
often
lengthi
mechan
ventil
thu
fi
nding
emphasis
use
exvivo
cultur
risk
assess
anim
virus
human
health
merscov
report
weak
induc
type
type
iii
interferon
immun
evas
mechan
relev
pathogenesi
interspeci
transmiss
diff
erenc
might
aff
ect
viru
replic
compet
new
host
therefor
investig
whether
human
merscov
dromedari
merscov
diff
ere
abil
evad
elicit
type
interferon
innat
immun
respons
multipl
infect
accur
control
experi
exvivo
cultur
human
bronchu
lung
use
epitheli
cell
line
deriv
human
lung
adenocarcinoma
use
cell
line
studi
viral
infect
human
respiratori
tract
human
merscov
emc
dromedari
merscov
dromedari
merscov
replic
effi
cientli
cell
although
dromedari
merscov
strain
replic
signifi
cantli
effi
cientli
cell
appendix
despit
effi
cient
viru
replic
viru
elicit
interferon
mrna
protein
respons
viru
infect
fi
gure
contrast
infl
uenza
viru
potent
induc
interferon
note
induct
interleukin
dromedari
merscov
strain
human
merscov
late
timepoint
post
infect
h
fi
gure
importantli
human
dromedari
merscov
behav
similarli
elicit
interferon
respons
suggest
virus
diff
er
evas
type
interferon
respons
view
high
preval
infect
dromedari
impli
frequent
human
exposur
rariti
human
infect
diseas
remain
puzzl
reminisc
epidemiolog
avian
infl
uenza
exact
mode
transmiss
merscov
dromedari
peopl
remain
unclear
whether
unusu
mode
exposur
host
suscept
role
investig
serolog
virolog
evid
merscov
dromedari
report
countri
east
north
africa
outsid
arabian
peninsula
zoonot
acquir
mer
yet
diagnos
human
be
african
contin
fi
nding
genet
diverg
dromedari
merscov
isol
egypt
phenotyp
similar
human
merscov
emc
explant
cultur
human
respiratori
tissu
underscor
possibl
zoonot
mer
might
occur
unrecognis
northeast
africa
beyond
present
mani
countri
test
merscov
patient
recent
travel
histori
arabian
peninsula
local
acquir
mer
could
miss
altern
diff
erenc
cultur
practic
camel
husbandri
mode
anim
contact
consumpt
anim
product
eg
fresh
camel
milk
might
account
diff
erenc
occurr
zoonot
diseas
diff
erent
geograph
region
conclus
fi
nding
suggest
dromedari
merscov
compet
infect
human
respiratori
tract
diff
er
phenotyp
human
merscov
respect
evid
strengthen
content
dromedari
camel
proxim
sourc
infect
human
be
fi
nding
also
emphasis
need
consid
mer
diff
erenti
diagnosi
viral
pneumonia
much
wider
geograph
region
northeast
africa
beyond
rwyc
plan
experi
exvivo
cultur
analys
data
contribut
draft
report
mgh
gk
aa
maa
fi
eld
studi
detect
viru
dromedari
specimen
plan
experi
dkwc
llmp
yg
genet
sequenc
phylogenet
analysi
kpt
invitro
cultur
quantit
pcr
assay
hyn
isol
merscov
strain
mcwc
involv
studi
design
obtain
research
fund
jmn
interpret
histolog
immunohistochemistri
studi
jsmp
obtain
research
fund
plan
coordin
studi
analys
data
wrote
report
author
contribut
data
interpret
analysi
provid
critic
comment
draft
report
declar
compet
interest
assess
infect
potenti
dromedari
camel
middl
east
respiratori
syndrom
coronaviru
merscov
strain
human
genet
analysi
complement
phenotyp
characteris
physiolog
relev
invitro
cell
cultur
search
pubm
report
publish
juli
term
mer
coronaviru
dromedari
cultur
isol
appli
date
languag
restrict
three
paper
retriev
two
relat
merscov
isol
dromedari
camel
one
recent
paper
yet
cite
pubm
identifi
ed
search
literatur
one
studi
pertain
phenotyp
characteris
dromedari
merscov
cell
cultur
vitro
studi
use
transform
human
hepatoma
cell
line
physiolog
relev
human
respiratori
tract
fi
nding
show
similar
viru
tropism
replic
compet
human
dromedari
merscov
exvivo
cultur
human
respiratori
tract
fi
nding
suggest
dromedari
merscov
arabian
peninsula
addit
genet
divers
dromedari
virus
egypt
infecti
human
be
exposur
zoonot
merscov
might
happen
wider
geograph
region
beyond
arabian
peninsula
virolog
evid
merscov
need
sought
patient
sever
unexplain
viral
pneumonia
africa
addit
middl
east
